Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.

Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.

Brian Gavin has over twenty-five years’ experience in the healthcare sector across a range of senior management positions both in Ireland and internationally. Most of his industry experience was with GlaxoSmithKline where he held a number of senior management positions including Global Commercial Strategy Manager for Seretide, Commercial Director for GSK Ireland and subsequently Corporate Affairs Director with the company.
Since 2009, Brian has provided consultancy services to a broad range of pharmaceutical companies including Almirall, Janssen, Biogen IDEC, Reckitt Benckiser, Mundipharma, Takeda, Bausch & Lomb, Bayer and InterMune.

He has extensive experience in the submission of HTA’s to the National Centre for Pharmacoeconomics and has completed desk and field-based research across a broad range of therapy areas. Developed over a number of years Brian has a comprehensive network of contacts across a broad spectrum of stakeholders in the Irish healthcare environment.

Declan is a Health Economist with broad experience in both the consultancy and industry environment. He graduated from National University of Ireland Galway (NUIG) with a B Comm in Economics, and gained an MSc in Health Economics from University College Cork (UCC). Declan has worked on wide-raging projects including: the development of HTA submissions and strategies in close collaboration with internal cross-functional teams and external stakeholders (NCPE, NICE, SMC); management of HTA processes and direct communication with associated stakeholders; development of business relationships with customers to promote regional awareness of company’s value proposition. Key attributes and skills Declan brings to the MAP team include HTA experience, project management, client engagement, pricing and reimbursement, and value demonstration.